Exchange: NASDAQ·Updated 07:30 PM EDT

SGRY News

News
all
press releases
Surgery Partners Director Teresa DeLuca Buys 11,250 Shares
Key PointsThe purchase was valued at approximately $161,000...
Nasdaq News: Markets
More News
Tuesday Sector Leaders: Hospital & Medical Practitioners, Cigarettes & Tobacco Stocks
In trading on Tuesday, hospital & medical practitioners shares were relative leaders, up on the day by about 1.8%. Leading the group were shares of Surgery Partners, up about 6.2% and shares of Ardent Health up about 3.8% on the day. Also showing relative strength are ciga...
Nasdaq News: Markets
Surgery Partners (SGRY) Q2 2026 Earnings Call Transcript
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...
Nasdaq News: Markets
Community Health Trades at a Deep Discount to Peers: Hold or Fold?
CYH trades at a deep discount to peers as acquisitions, cost control and debt reduction progress, but cash flow remains a concern.
Zacks
Likely ETF & Stock Winners From July Jobs Report
Weak July jobs data raises hopes for Fed easing, putting health care and select retail ETFs and stocks in focus.
Zacks
Surgery Partners (SGRY) Q2 Earnings and Revenues Beat Estimates
Surgery Partners (SGRY) delivered earnings and revenue surprises of +400.00% and +1.62%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Beat the Market Like Zacks: Aveanna, FactSet, Shopify in Focus
AVAH, FDS and SHOP lead Zacks' recent standouts, with several picks posting strong gains versus the S&P 500.
Zacks
CryoPort, Inc. (CYRX) Reports Q2 Loss, Beats Revenue Estimates
CryoPort (CYRX) delivered earnings and revenue surprises of 0.00% and +1.85%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Biodesix, Inc. (BDSX) Reports Q2 Loss, Beats Revenue Estimates
Biodesix (BDSX) delivered earnings and revenue surprises of +17.44% and +2.92%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Strength Seen in Surgery Partners (SGRY): Can Its 5.3% Jump Turn into More Strength?
Surgery Partners (SGRY) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Zacks

Advertisement|Remove ads.